Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Ogihara

Showing results (31-40 of 337) with videos related to

Pageof 34
Sort By:
Annals of the New York Academy of Sciences|May 22, 2002
Genetic dissection of type 1 diabetes susceptibility gene, Idd3, by ancestral haplotype congenic mappingHiroshi Ikegami, Tomomi Fujisawa, Susumu Makino, et al.
Clinical Therapeutics|August 6, 2010
Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT studyKazuyuki Shimada, Toshio Ogihara, Takao Saruta, et al.
Annals of the New York Academy of Sciences|December 18, 2003
Congenic mapping and candidate sequencing of susceptibility genes for Type 1 diabetes in the NOD mouseHiroshi Ikegami, Tomomi Fujisawa, Susumu Makino, et al.
Current Diabetes Reviews|January 29, 2008
Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosisHironori Nakagami, Yasufumi Kaneda, Toshio Ogihara, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potentialShuko Takeda, Naoyuki Sato, Toshio Ogihara, et al.
Endocrine Journal|August 31, 2002
Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular diseaseRyuichi Morishita, Motokuni Aoki, Yoshikage Yo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 6, 2010
Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOSHiromi Rakugi, Toshio Ogihara, Yoshio Goto, et al.
Current Opinion in Pharmacology|April 6, 2004
Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotidesRyuichi Morishita, Naruya Tomita, Yasufumi Kaneda, et al.
Expert Review of Cardiovascular Therapy|May 14, 2005
Hepatocyte growth factor as potential cardiovascular therapyHironori Nakagami, Yasufumi Kaneda, Toshio Ogihara, et al.
Expert Review of Cardiovascular Therapy|October 23, 2008
ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trialToshio Ogihara, Akira Fujimoto, Kazuwa Nakao, et al.
Pageof 34

Showing results (31-40 of 337) with videos related to

Sort By:
Pageof 34
Annals of the New York Academy of Sciences|May 22, 2002
Genetic dissection of type 1 diabetes susceptibility gene, Idd3, by ancestral haplotype congenic mappingHiroshi Ikegami, Tomomi Fujisawa, Susumu Makino, et al.
Clinical Therapeutics|August 6, 2010
Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT studyKazuyuki Shimada, Toshio Ogihara, Takao Saruta, et al.
Annals of the New York Academy of Sciences|December 18, 2003
Congenic mapping and candidate sequencing of susceptibility genes for Type 1 diabetes in the NOD mouseHiroshi Ikegami, Tomomi Fujisawa, Susumu Makino, et al.
Current Diabetes Reviews|January 29, 2008
Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosisHironori Nakagami, Yasufumi Kaneda, Toshio Ogihara, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potentialShuko Takeda, Naoyuki Sato, Toshio Ogihara, et al.
Endocrine Journal|August 31, 2002
Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular diseaseRyuichi Morishita, Motokuni Aoki, Yoshikage Yo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 6, 2010
Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOSHiromi Rakugi, Toshio Ogihara, Yoshio Goto, et al.
Current Opinion in Pharmacology|April 6, 2004
Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotidesRyuichi Morishita, Naruya Tomita, Yasufumi Kaneda, et al.
Expert Review of Cardiovascular Therapy|May 14, 2005
Hepatocyte growth factor as potential cardiovascular therapyHironori Nakagami, Yasufumi Kaneda, Toshio Ogihara, et al.
Expert Review of Cardiovascular Therapy|October 23, 2008
ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trialToshio Ogihara, Akira Fujimoto, Kazuwa Nakao, et al.
Pageof 34